Market Research Reports and Industry Reports

Fulcrum Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Summary

Fulcrum Therapeutics Inc (Fulcrum Therapeutics) is a biotechnology company which focuses on the discovery and development of small molecule therapies to unlock the gene control. Its pipeline portfolio includes Fragile X syndrome (FXS) and facioscapulohumeral muscular dystrophy (FSHD). Fulcrums product engine intends to develop disease-modifying therapies for various diseases across therapeutic areas such as Central Nervous System, Neuromuscular and Cardiovascular, among others. The company will also focuses on monogenic diseases which occur due to a faulty regulation of a single gene. Fulcrum Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Fulcrum Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Fulcrum Therapeutics Raises Additional Funds through Series A Financing 10
Fulcrum Therapeutics Raises USD55 Million in Series A Financing 11
Partnerships 12
Horizon Discovery Enters into Agreement with Fulcrum Therapeutics 12
Fulcrum Therapeutics Inc - Key Competitors 13
Fulcrum Therapeutics Inc - Key Employees 14
Fulcrum Therapeutics Inc - Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
May 03, 2017: Fulcrum Therapeutics Expands Leadership Team with Appointment of Owen Wallace, Ph.D., as Chief Scientific Officer and Amit Hasija as Chief Business Officer 16
Feb 07, 2017: Fulcrum Therapeutics Strengthens its Board of Directors with the Addition of Alan Ezekowitz, MBChB, D.Phil., and James J. Collins, Ph.D. 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fulcrum Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Fulcrum Therapeutics Raises Additional Funds through Series A Financing 10
Fulcrum Therapeutics Raises USD55 Million in Series A Financing 11
Horizon Discovery Enters into Agreement with Fulcrum Therapeutics 12
Fulcrum Therapeutics Inc, Key Competitors 13
Fulcrum Therapeutics Inc, Key Employees 14

List Of Figures


Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fulcrum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Fulcrum Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fulcrum Therapeutics Inc (Fulcrum Therapeutics) is a biotechnology company which focuses on the discovery and development of small molecule therapies to unlock the gene control. Its pipeline portfolio includes Fragile

USD 250View Report

Fulcrum Utility Services Limited Strategic Analysis Review- Fulcrum Utility Services Limited SWOT, Outlook, Operations and Financial Profile

Fulcrum Utility Services Limited Company Profile provides strategic analysis of Fulcrum Utility Services Limited Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research

USD 200View Report

FULCRUM UTILITY SERVICES LD Strategic Analysis Review- FULCRUM UTILITY SERVICES LD SWOT, Outlook, Operations and Financial Profile

FULCRUM UTILITY SERVICES LD Company Profile provides strategic analysis of FULCRUM UTILITY SERVICES LD Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research

USD 200View Report

Respira Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Respira Therapeutics Inc (Respira) is a provider of dry powder inhaler technologies. The company develops robust portfolio of inhaled drug products for orphan pulmonary diseases. Its products under development are

USD 250View Report

Blackthorn Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Blackthorn Therapeutics Inc (Blackthorn Therapeutics) is a clinical-stage biopharmaceutical company which discovers and develops novel targeted treatments for neurobehavioral disorders. The company is building pipeline of small molecule modulates which

USD 250View Report

Viracta Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Viracta Therapeutics Inc (Viracta) is a drug development company which focuses on the development of proprietary viral activation therapy platform to address cancers associated with the Epstein-Barr Virus (EBV) and

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Aug 2017
No. of Pages :18
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
paykasa bozdurma,paykasa bozdurma,astropay bozdurma,paykasa,paykasa,paykasa bozdurma,paykasa,astropay bozdurma,justin kart,bitcoin bozdurma,paykasa bozum,paykasa kart bozdurma,
beylikduzu escort,bahçeşehir escort,escort istanbul,istanbul escort,sex hikayeleri,pendik escort,
pedalebiellese.com,
istanbul escort bayan,besiktas escort,maltepe escort,kadikoy escort bayan,tekirdag escort bayan,findikzade escort,antalya escort bayan,ankara escort bayan,
Böcek İlaçlama,şehirler arası nakliyat,şehirler arası evden eve nakliyat,ofis taşıma,gebze evden eve nakliyat,kadıköy evden eve nakliyat,istanbul evden eve nakliyat,epoksi zemin,
ankara escort,ankara escort,ankara escort,
tipobet,
seo teknikleri wordpress ücretsiz tema istanbul sexs shop hacklink e sigara sexs shop